Home Healthcare Medical Devices Neurovascular Devices Market

Neurovascular Devices Market Size, Share & Trends Analysis Report By Product (Embolization Devices, Revascularization Devices Inactivated Vaccines, Thrombectomy Devices, Embolic Protection Devices, Accessory Devices), By Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), Ischemic Stroke, Stenosis, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Neurovascular Devices Market Size Analysis
    1. Introduction
    2. Neurovascular Devices Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Embolization Devices
      2. Revascularization Devices Inactivated Vaccines
      3. Thrombectomy Devices
      4. Embolic Protection Devices
      5. Accessory Devices
    3. Neurovascular Devices Market Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
      1. Aneurysm
      2. Arteriovenous Malformation and Fistulas (AVM)
      3. Ischemic Stroke
      4. Stenosis
      5. Others
  7. North America Neurovascular Devices Market Size Analysis
    1. Introduction
    2. Neurovascular Devices Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Embolization Devices
      2. Revascularization Devices Inactivated Vaccines
      3. Thrombectomy Devices
      4. Embolic Protection Devices
      5. Accessory Devices
    3. Neurovascular Devices Market Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
      1. Aneurysm
      2. Arteriovenous Malformation and Fistulas (AVM)
      3. Ischemic Stroke
      4. Stenosis
      5. Others
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
  8. Europe Neurovascular Devices Market Size Analysis
    1. Introduction
    2. Neurovascular Devices Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Embolization Devices
      2. Revascularization Devices Inactivated Vaccines
      3. Thrombectomy Devices
      4. Embolic Protection Devices
      5. Accessory Devices
    3. Neurovascular Devices Market Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
      1. Aneurysm
      2. Arteriovenous Malformation and Fistulas (AVM)
      3. Ischemic Stroke
      4. Stenosis
      5. Others
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    6. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
  9. APAC Neurovascular Devices Market Size Analysis
    1. Introduction
    2. Neurovascular Devices Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Embolization Devices
      2. Revascularization Devices Inactivated Vaccines
      3. Thrombectomy Devices
      4. Embolic Protection Devices
      5. Accessory Devices
    3. Neurovascular Devices Market Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
      1. Aneurysm
      2. Arteriovenous Malformation and Fistulas (AVM)
      3. Ischemic Stroke
      4. Stenosis
      5. Others
    4. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    7. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
  10. Middle East and Africa Neurovascular Devices Market Size Analysis
    1. Introduction
    2. Neurovascular Devices Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Embolization Devices
      2. Revascularization Devices Inactivated Vaccines
      3. Thrombectomy Devices
      4. Embolic Protection Devices
      5. Accessory Devices
    3. Neurovascular Devices Market Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
      1. Aneurysm
      2. Arteriovenous Malformation and Fistulas (AVM)
      3. Ischemic Stroke
      4. Stenosis
      5. Others
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
  11. LATAM Neurovascular Devices Market Size Analysis
    1. Introduction
    2. Neurovascular Devices Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Embolization Devices
      2. Revascularization Devices Inactivated Vaccines
      3. Thrombectomy Devices
      4. Embolic Protection Devices
      5. Accessory Devices
    3. Neurovascular Devices Market Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
      1. Aneurysm
      2. Arteriovenous Malformation and Fistulas (AVM)
      3. Ischemic Stroke
      4. Stenosis
      5. Others
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Embolization Devices
        2. Revascularization Devices Inactivated Vaccines
        3. Thrombectomy Devices
        4. Embolic Protection Devices
        5. Accessory Devices
      3. Market Size & Forecast By Disease Pathology 2022-2034 (USD MILLION/ Units)
        1. Aneurysm
        2. Arteriovenous Malformation and Fistulas (AVM)
        3. Ischemic Stroke
        4. Stenosis
        5. Others
  12. Competitive Landscape
    1. Neurovascular Devices Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. B. Braun Melsungen AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Integer Holdings Corporation
    3. Johnson & Johnson
    4. Microport Scientific Corporation
    5. Penumbra, INC.
    6. Phenox GmbH
    7. Stryker Corporation
    8. Terumo Corporation
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.